Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

13.26 +0.58 (+4.53%)

Delayed Quote Updated: 12:17 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

3 Cash-Burning Stocks We’re Skeptical Of

September 19, 2025

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...

Via StockStory

Why Integra LifeSciences (IART) Stock Is Down Today

September 08, 2025

Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 3.6% in the afternoon session after the U.S. Food and Drug Administration (FDA) issued a warning letter regarding violations at...

Via StockStory

Topics Economy

September 02, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Spotting Winners: Integra LifeSciences (NASDAQ:IART) And Surgical Equipment & Consumables - Specialty Stocks In Q2

August 27, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

3 Russell 2000 Stocks We’re Skeptical Of

August 22, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

Integra LifeSciences, IQVIA, Avantor, National Vision, and United Airlines Shares Plummet, What You Need To Know

August 21, 2025

A number of stocks fell in the morning session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell.

Via StockStory

Topics Economy Stocks

IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook

August 13, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $415.6 million. The company expects...

Via StockStory

Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Lawsuit

3 Value Stocks with Warning Signs

August 11, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

1 Volatile Stock to Target This Week and 2 We Avoid

August 07, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

3 Stocks Under $50 We Approach with Caution

August 05, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

Integra (IART) Q2 Revenue Beats by 5% ↗

July 31, 2025

Via The Motley Fool

Integra LifeSciences Holding (NASDAQ:IART) Reports Q2 2025 Earnings Beat Amid Mixed Market Reaction ↗

July 31, 2025

Integra LifeSciences (IART) Q2 2025 earnings beat revenue and EPS estimates, but shares dipped pre-market. Strong performance in neurosurgery and wound care segments drives growth.

Via Chartmill

Topics Earnings

Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets

July 31, 2025

Via StockStory

Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings

July 29, 2025

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for.

Via StockStory

3 Profitable Stocks We Think Twice About

July 24, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know

July 18, 2025

A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like...

Via StockStory

Topics Lawsuit World Trade

Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.

Via StockStory

Topics ETFs Stocks World Trade

3 Out-of-Favor Stocks with Open Questions

July 02, 2025

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value...

Via StockStory

3 Small-Cap Stocks with Mounting Challenges

June 23, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Topics Energy

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

June 20, 2025

Via ACCESS Newswire

3 Value Stocks Skating on Thin Ice

June 20, 2025

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

June 18, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

June 15, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

June 10, 2025

From Pomerantz LLP

Via GlobeNewswire

3 Volatile Stocks with Bad Fundamentals

June 09, 2025

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

Via StockStory

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

June 06, 2025

From Pomerantz LLP

Via GlobeNewswire

Surgical Equipment & Consumables - Specialty Stocks Q1 In Review: Integra LifeSciences (NASDAQ:IART) Vs Peers

June 03, 2025

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Integra LifeSciences (NASDAQ:IART) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART

June 02, 2025

From Pomerantz LLP

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.